FOXC2 and cancer: Another previously unappreciated function of FOXC2 revealed by our data is its negative regulation of genes associated with IFN signaling, a finding that is particularly intriguing in light of recent studies demonstrating that both type I IFN and IFNγ signaling pathways within tumor cells are critical to the efficacy of cancer immunotherapies (34–37).